Wednesday, Mar 11, 2026
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"granules-india-limited"
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults
Latest News
SICA hosts memorial Carnatic concert in Hyderabad
3 hours ago
National IP Yatra-2026 concludes at SR University in Warangal
3 hours ago
Iran war may push fuel prices up: Harish Rao
3 hours ago
Rising heat suspected in mass chicken deaths at Siddipet poultry farm
3 hours ago
Annual General Body Meeting of the Rugby Association of Telangana held
4 hours ago
Godavari Pushkaralu to be organised on the lines of Kumbh Mela: Sridhar Babu
4 hours ago
Para shuttler Krishna Nagar clinches ‘double’ in 7th Senior Nationals
4 hours ago
Madhusudan clinches ‘triple’ crown in ITF tennis championship
4 hours ago
.